Visit our USA website
Re:Cognition Health is absolutely delighted to be shortlisted in the Growing Business Awards in the Bridges Positive Impact category.
The Growing Business Awards, which are celebrating their 21st year, honour the UK’s most outstanding entrepreneurs and high-growth businesses.
Our team of brain and mind experts have been recognised for their dedication and determination to making a positive impact to individuals living with dementia through their commitment to solving the unacceptable problem. Together we are making a huge societal impact through delivering international clinical trials and providing individuals with access to new-generation medications.
Lead by Dr Emer MacSweeney, CEO and Consultant Neuroradiologist, Re:Cognition Health is now the fastest growing company world-wide, providing people access to new treatments for Alzheimer’s disease, the most common cause of dementia. Our award-winning team is passionate about providing hope and working to improve the lives of millions of people affected, directly or indirectly, with cognitive disorders, the most prevalent of which is Alzheimer’s Disease. We are also ambitious about our company growth, aiming to open more centres in the UK and USA in order to help more people living with cognitive disorders.
We are thrilled to be shortlisted for the Positive Impact category in the Growing Business Awards and we are very much look forward to celebrating at the awards ceremony in November. We are also delighted to be finalists in the Societal Impact category at the
EY Entrepreneur Of The Year™ 2019 UK. The national winners will be announced on 7th November and we are eagerly awaiting the awards ceremony and the results!
